## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `pt-141-selank-ssri`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/pt-141-selank-ssri/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-selank-ssri/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `pt-141-selank-ssri` v17 · content_hash `f187864d19b2e749…` · thread_head genesis · 17 DIVs
- **thesis (c1):** PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs showing improved desire and reduced distress.
  - c3 [human/active] No published human trials examine PT-141 or Selank specifically in SSRI users or their combination.
  - c17 [human/active] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - c_map_pt-141-selank-ssri [system/active] Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); cat
  - c20 [system/active] PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This 
  - c5 [mechanistic/active] Selank influences GABA-A receptors and exhibits non-benzodiazepine anxiolytic activity in transcriptomic studies.
  - c6 [anecdotal/active] User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.
  - c7 [anecdotal/active] User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-selank-ssri/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-selank-ssri/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `pt-141-selank-ssri`
- **title:** PT-141 + Selank for SSRI Users: Evidence Review
- **url:** https://miscsubjects.com/a/pt-141-selank-ssri
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:10.196Z
- **tags:** peptide, topic

## Body

## PT-141 (Bremelanotide) Evidence

PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.

Human trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.

## Selank Evidence

Selank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.

Additional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.

## Mechanisms (Mechanistic Tier)

PT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways.

Selank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies.

## Combination and SSRI Context

No human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative.

## Evidence Summary

- PT-141: Human (FDA approval and phase 3 trials for HSDD).
- Selank: Human (Russian clinical trials for GAD; limited Western validation).
- SSRI-specific effects or stack: Speculative (no supporting data).

---

Related:
[Selank](/a/selank) · [PT-141](/a/pt-141)

[[embed:selank]]

[[embed:pt-141]]

## Claims (16)

- **c21** [mechanistic w=0.3] Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  - who_claims: miscsubjects protocol
  - slot: limitations
- **c3** [human w=0.8] No published human trials examine PT-141 or Selank specifically in SSRI users or their combination.
  - who_claims: grok/4.3-populate
- **c_map_pt-141-selank-ssri** [system w=0.35] Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); catalog.degen_score for SSRIs.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
- **c20** [system w=0.35] PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
  - who_claims: miscsubjects protocol
  - slot: what_it_is
- **c1** [human w=0.8] PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs showing improved desire and reduced distress.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
  - sources: s1, s2
- **c17** [human w=0.8] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - who_claims: system/protocol
  - slot: disclaimer
- **c5** [mechanistic w=0.3] Selank influences GABA-A receptors and exhibits non-benzodiazepine anxiolytic activity in transcriptomic studies.
  - who_claims: grok/4.3-populate
  - slot: mechanism
  - sources: s3
- **c6** [anecdotal w=0.3] User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s6
- **c7** [anecdotal w=0.3] User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s7
- **c8** [anecdotal w=0.3] Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s8
- **c11** [anecdotal w=0.3] Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s11
- **c12** [anecdotal w=0.3] Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s12
- **c19** [anecdotal w=0.3] Anecdotal reports suggest potential benefits and risks when combining PT-141 and Selank with SSRIs, but these are not systematically collected or analyzed.
  - who_claims: kimi-collaborator
  - slot: who_claims_what
  - sources: s6, s7, s8, s11, s12
- **c2** [speculative w=0.12] Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.
  - who_claims: commercial vendors
  - slot: who_claims_what
  - sources: s3, s4, s9
- **c4** [speculative w=0.12] PT-141 modulates central melanocortin receptors for arousal signaling.
  - who_claims: grok/4.3-populate
  - slot: mechanism
  - sources: s5
- **c10** [speculative w=0.12] Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.
  - who_claims: grok/grok-4.3
  - slot: what_is_unknown
  - sources: s10

## Voxel graph (16 atoms · 34 edges)
- full graph: https://miscsubjects.com/api/articles/pt-141-selank-ssri/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (12)
- chain valid: yes · head: `2e176a269e1cb8ec`

### s1 · clinical_trial · ok
- title: Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/
- summary: Phase 3 RCT results supporting FDA approval for HSDD.
- quote: Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.
- claim_ids: c1
- hash: `8cb7132426dab2b0`

### s2 · medical · ok
- title: VYLEESI Prescribing Information
- url: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf
- summary: Official FDA label confirming approval and indication.
- quote: VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
- claim_ids: c1
- hash: `1eda35af19a69dc5`

### s3 · pubmed · ok
- title: Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/
- summary: Reviews Russian clinical data on Selank for anxiety without typical benzo side effects.
- quote: Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.
- claim_ids: c2, c5
- hash: `51b7eb5f10c183a3`

### s4 · pubmed · http_403
- title: Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
- url: https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia
- summary: Details 62-patient RCT comparing Selank to benzodiazepine.
- quote: The effect of selank (30 patients) was compared to that of medazepam (32 patients).
- claim_ids: c2
- hash: `4d85ce22bf80813a`

### s5 · medical · http_403
- title: Bremelanotide: Uses, Interactions, Mechanism of Action
- url: https://go.drugbank.com/drugs/DB11653
- summary: Confirms central melanocortin mechanism.
- quote: Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.
- claim_ids: c4
- hash: `d492018039f27e4b`

### s6 · reddit · ok
- title: Selank peptides, Can you take it with escitaloprám.
- url: https://www.reddit.com/r/PeptideForum/comments/1mo483x/selank_peptides_can_you_take_it_with_escitalopr%C3%A1m/
- summary: User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.
- quote: BUT I am on 5mg of escitalopram and Selank and my Dr said it was fine. So, while my case is similar, its not exactly the same but similar.
- claim_ids: c6, c19
- hash: `120a99c95b098311`

### s7 · reddit · ok
- title: Anyone taking Semax and Selank. What is your experience
- url: https://www.reddit.com/r/PeptideForum/comments/1qjtdfv/anyone_taking_semax_and_selank_what_is_your/
- summary: User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.
- quote: I love the S&S blend off crafters. It’s pretty good as I have anxiety And take Zoloft. It works with my current prescription.
- claim_ids: c7, c19
- hash: `e492c8fd21d23899`

### s8 · reddit · ok
- title: Full PT-141 Guide
- url: https://www.reddit.com/r/BodyHackGuide/comments/1qt7vsg/full_pt141_guide/
- summary: Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.
- quote: This is why people use it for: • Low libido • Performance anxiety • SSRI sexual sides • “Everything works but I don’t feel it”
- claim_ids: c8, c19
- hash: `6285e700750a2e5f`

### s9 · other · ok
- title: PT-141 - Peptide Affect
- url: https://peptideaffect.com/pt-141/
- summary: Discusses peptide stacks including PT-141 with Selank for anxiety/libido balance and notes potential unpredictable interactions when combining PT-141 with SSRIs.
- quote: PT-141 + Selank – Calm and Desire Balance
**Summary:** A calming, balanced stack for those who experience anxiety or performance-related inhibition.
**Why it works:** Selank reduces anxiety by supporting GABA signaling in the brain. This can help relax the nervous system and remove emotional blocks to desire.

PT-141 + SSRIs or Dopaminergic Medications – Unpredictable Mood Interactions
**Summary:** Combining PT-141 with prescription mood medications (especially SSRIs or dopam
- claim_ids: c2
- hash: `a9ecf8093d38cfcc`

### s10 · medical · ok
- title: Peptides With Psychiatric Medications: A Psychiatrists Guide
- url: https://thebh.us/blog/peptides-with-psychiatric-medications/
- summary: Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.
- quote: Selank is the more cautious case. The peptide slows enzymatic breakdown of serotonin in certain brain regions, which increases serotonin availability through a different mechanism than an SSRI’s reuptake blockade, but in the same direction. The combination is not equivalent to stacking two direct serotonergic drugs, and it is not the same as combining an SSRI with an MAOI (the classic high-risk pairing for serotonin syndrome). It is, however, not zero either.
- claim_ids: c10
- hash: `9104c13f94db494f`

### s11 · reddit · ok
- title: Has anyone tried PT-141, selank, or semax?
- url: https://www.reddit.com/r/PeptideDiscussion/comments/1ra5gba/has_anyone_tried_pt141_selank_or_semax/
- summary: Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.
- quote: Has anyone tried PT-141 , selank , or semax? These are kind of the brain stimulating peptides that are supposed to be fast acting. I was ...
- claim_ids: c11, c19
- hash: `479918a0f3600e9d`

### s12 · reddit · ok
- title: Love Potion (PT141-Selank-Oxytocin) nasal spray
- url: https://glp1forum.com/threads/love-potion-pt141-selank-oxytocin-nasal-spray.18608/
- summary: Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.
- quote: Minus oxytocin (personally, subq was a nightmare), selank and PT-141 seem better to me at least, subcutaneous. First time, 0.6 mg PT-141 .
- claim_ids: c12, c19
- hash: `2e176a269e1cb8ec`

## Provenance (17 model passes)
- chain valid: yes · head: `b995ed4fc3b5f987`

- repair · system/audit-repair · 2026-06-29T12:46 · hash `cb05af9db625`
- repair · system/audit-repair · 2026-06-29T13:25 · hash `e7bcc4e75591`
- repair · system/audit-repair · 2026-06-29T13:25 · hash `a0806a36b128`
- collaborate · kimi/moonshot-v1-8k · 2026-06-29T13:55 · hash `ac396382a518`
- repair · repair · 2026-06-29T20:06 · hash `8a2b90eb1cb9`
- claim · fill-slots · 2026-06-29T21:17 · hash `401079f20792`
- claim · fill-slots · 2026-06-29T21:17 · hash `f974caffb2f7`
- voxel_divide · owner · 2026-07-17T02:41 · hash `b995ed4fc3b5`

## Question graph
- questions: 0 · evidence ingests: 1

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/pt-141-selank-ssri/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/pt-141-selank-ssri/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-selank-ssri","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-selank-ssri|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-selank-ssri|tier|assertion`
- **iMessage ask:** `pt-141-selank-ssri|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `pt-141-selank-ssri`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-selank-ssri/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*